Abstract
The usual management of opportunistic fusarium infection in the immunocompromized patient is with systemic antifungals, despite which little impact is made on the mortality which approaches 100%. We describe a case of fusarwm infection of the foot in a bone marrow tranplant reciplent which was successfully managed with local wide excisional surgery and intravenous liposomal amphotericin B.